Furthermore, miR-451a could regulate survival of NSCLC cells through the inhibition of ras-related protein 14 (RAB14) and might to be a promising therapeutic target for NSCLC patients [49]. The gene discussed is RAB14; the disease is non-small cell lung carcinoma.